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Abstract
We describe a high-resolutionmelting (HRM) analysis method that is rapid, reproducible,
and able to identify reference strains and further 40 clinical isolates of Aspergillus fumi-
gatus (14), A. lentulus (3), A. terreus (7), A. flavus (8), A. niger (2), A. welwitschiae (4),
and A. tubingensis (2). Asp1 and Asp2 primer sets were designed to amplify partial se-
quences of the Aspergillus benA (beta-tubulin) genes in a closed-, single-tube system.
Human placenta DNA, further Aspergillus (3), Candida (9), Fusarium (6), and Scedospo-
rium (2) nucleic acids from type strains and clinical isolates were also included in this
study to evaluate cross reactivity with other relevant pathogens causing invasive fungal
infections. The barcoding capacity of this method proved to be 100% providing distinc-
tive binomial scores; 14, 34, 36, 35, 25, 15, 26 when tested among species, while the
within-species distinction capacity of the assay proved to be 0% based on the aligned
thermodynamic profiles of the Asp1, Asp2 melting clusters allowing accurate species
delimitation of all tested clinical isolates. The identification limit of this HRM assay was
also estimated on Aspergillus reference gDNA panels where it proved to be 10–102 ge-
nomic equivalents (GE) except theA. fumigatus panel where it was 103 only. Furthermore,
misidentification was not detected with human genomic DNA or with Candida, Fusarium,
and Scedosporium strains. Our DNA barcoding assay introduced here provides results
within a few hours, and it may possess further diagnostic utility when analyzing standard
cultures supporting adequate therapeutic decisions.
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Introduction
Invasive fungal infections (IFI) are associated with high
lethality rates representing a serious health problem in
immunocompromised patients. Aspergilli are among the
most significant fungal etiological agents of life-threatening
invasive infections especially in patients with neutrope-
nia, hematologic malignancies (acute leukemia) and in
patients undergoing hematopoietic stem cell transplanta-
tion.1,2 Even with underestimated, poor epidemiological
data the burden of invasive aspergillosis (IA) is on the rise.3
This expansion is due to improved antimicrobial therapies
and supportive care raising the number of severely immuno-
compromised patients thus putting them at higher risk of
acquiring opportunistic fungal infections.4
Aspergillus fumigatus is the prominent agent of IA5;
however, several other species have also been reported from
various clinical samples, such as A. terreus, A. flavus and
A. niger.6–12 Recently, IA cases due to rare Aspergilli such
as A. lentulus have also been reported having low in vitro
susceptibilities to a wide range of antifungals including am-
photericin B, azoles, echinocandins.13,14 In clinical settings
misidentification of A. lentulus with A. fumigatus has been
increasingly reported by clinical laboratories.15 Infections
due to A. terreus are also difficult to treat because of their
refractoriness to certain antifungal drugs, often causing dis-
seminated infections with increased lethality.16 The cor-
rect and prompt identification of Aspergillus species is of
high importance because knowledge of species identity may
influence adequate antifungal therapy given that different
species have variable susceptibilities to multiple antifungal
drugs.17–20
Mortality among intensive care unit (ICU) patients with
IA can be as high as 90% but the overall mortality rate
for IA is about 50% if diagnosed timely and treated.21,22
Accurate diagnosis of IA raises challenges to clinical mi-
crobiology laboratories. Clinical signs and symptoms are
non-specific and standard culture-based diagnostics are typ-
ically too insensitive or nonspecific.23 Identification of un-
known Aspergillus clinical isolates to species is a polypha-
sic approach including morphotyping, growth temperature
regimes, investigation of drug susceptibility patterns, and
molecular characterization.24 Furthermore, clinical isolates
are not necessarily morphologically uniform representing
aberrant conidiophore formation, therefore mistaken iden-
tification of species by morphological characteristics have
occurred in the past.14 Since culture techniques typically
require specialized expertise for recovery and species deter-
mination, many laboratories can rely only on DNA based
methodologies.25,26
Surrogate-marker based molecular assays can provide
better prognostic data. In routine clinical settings, the de-
tection of Aspergillus galactomannan (GM) is based on
labor intensive, well standardized Platelia-Aspergillus en-
zyme immunoassay (EIA), which is considered to be
the gold-standard possessing numerous attractive features.
Nevertheless, as GM is a panfungal marker it is not suitable
for the identification of Aspergilli to the species level.27–29
There is a dire need for the development of newer diagnos-
tic techniques to identify causative agents to species rapidly,
noninvasively, and at an early stage of the disease.
Molecular techniques in addition to morphological iden-
tification have been shown to offer high resolution of species
within the genus.14 Recent, multiple studies prove that poly-
merase chain reaction (PCR)-based techniques appear to
be promising in terms of speed, economy, and resolution
power with available methodological recommendations to
facilitate both manual and automated nucleic extraction
technology.30–34
Molecular barcoding relies on short, conserved genetic
markers in the genome permitting the specific identification
of the different species.35–37 Recently, fast, high throughput
post-PCR due to high-resolution melting analysis has been
developed and effectively used for this reason.38 High res-
olution melting (HRM) analysis is able to determine accu-
rately the relationship between temperature and the extent
of denaturation of DNA in the presence of saturating, dou-
ble stranded DNA intercalating dyes.39 The denaturation of
the different DNA fragments with increasing temperature
defines the characteristic melting domains and the shape
of the derivative melting curves represents the taxonomic
signatures of the here-tested species.
This paper describes the development of an HRM based
molecular barcoding assay tailored to prompt, accurate
identification to the species level of clinically relevant As-
pergillus isolates. Our sequence typing method targets two
different regions of Aspergillus benA genes for the specific
identification and discrimination of different clinical iso-
lates of Aspergilli to the species level. Due to the fact that
this HRM technique generates duplex, distinct peaks in case
of differentAspergillus species, our method introduced here
has a high resolving power with a short turnaround time
reducing the risk of contamination and saving expenses.
These features make our method advantageous for use as a
first-pass diagnostic adjunct in microbiology laboratories.
Materials and methods
Collection and identification of fungal strains
used in this study
Genomic DNA samples of clinically relevant Aspergillus,
Candida, Fusarium, and Scedosporium strains were ex-
amined. The reference strains and the clinical isolates
(Table 1) were maintained at the Department of Microbiol-
ogy, University of Szeged on Sabouraud—chloramphenicol
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Table 1. List of the reference and clinical strains examined by Asp1–Asp2 duplex HRM assay.
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Table 1. continued
Note: The six Aspergillus (FGSC A1156, Af293, CBS 117885, NRRL 11611, CBS 113.46, CBS 134.48) and the two Candida reference strains (ATCC 22019,
ATCC 10231) are highlighted in black. Clinical isolates are from the SzegedMicrobiology Collection (SZMC). Reference strains are from: (FGSC); Fungal Genetics
Stock Center, (CBS); Centraalbureau voor Schimmelcultures, Fungal and Yeast Collection; (NRRL); Northern regional Research Laboratories, (ATCC); American
Type Culture Collection.
slant agar and periodically subcultured. The species level
identifications of the different clinical isolates were car-
ried out by conventional morphological methods and
the results were confirmed by sequence analysis of part
of the calmodulin (Aspergilli), ribosomal RNA (Can-
dida and Scedosporium species), and TEF1-alpha (Fusaria)
genes.
DNA extraction
All fungal DNA extraction steps were performed in a class
II laminar-flow cabinet to avoid environmental contamina-
tion.
 Aspergillus reference strains and clinical isolates were
cultivated on standard minimal nitrate medium.40 As-
pergillus genomic DNA extraction was carried out at the
University of Debrecen and at the University of Szeged.
DNA was isolated from liquid cultures grown in mini-
mal medium at 37◦C (A. fumigatus, A. niger), 25◦C (A.
terreus, A. lentulus, A. flavus, A. tubingensis) and 30◦C
(A. welwitschiae) at 220 rpm for 18 h. The mycelium
was disrupted by Roche MagNa Lyser (Roche Diagnos-
tics, Risch-Rotkreuz, Switzerland), and genomic DNA
was isolated using the Genomic DNA Purification Kit
(Thermo Scientific, Maryland, USA) according to the
manufacturer’s instructions.
 Candida, Fusarium, and Scedosporium cultures used
for the molecular barcoding were grown on yeast pep-
tone D-glucose (YPD) broth for 2 days, and DNA
was extracted from the strains using the MasterpureTM
Yeast DNA Purification Kit (Epicentre Biotechnol.,
Madison, USA) according to the manufacturer’s
instructions.41
Asp1-Asp2 HRM assay design
Annotated Aspergillus benA genes were extracted from
public databases to make multiple alignments using Clustal
Omega. When designing primers, three main criteria were
considered: (i) the amplicon length beyond 200 bp was con-
sidered to be maleficent, (ii) the length of forward and re-
verse primers should be beyond 18 bp to enhance specificity
and proper hybridization to the target regions, (iii) ampli-
cons should cover enough mismatches to enable proper dis-
crimination among the tested strains.
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Verification of the amplicons
Before applying the Asp1 and Asp2 primer sets (Fig. 1) on
Aspergillus clinical isolates we pretested them on the ge-
nomic DNA of A. fumigatus (Af293), A. lentulus (CBS
117885), A. terreus (FGSC A1156), A. flavus (NRRL
11611),A. niger (CBS 113.46),A. tubingensis (CBS 134.48)
reference strains. The yielded Asp1 and Asp2 benA ampli-
cons were electrophoresed on 1% TAE-agarose gel stained
with ethidium-bromide. PCR products were purified
using post-reaction clean-up columns (Sigma-Aldrich,
Missouri, USA). For capillary sequencing BigDye R© Ter-
minator v3.1 Cycle Sequencing Kit (Thermo Scientific,
Maryland, USA) was used. Cycle sequencing PCR was
performed according to manufacturers’ protocol. Capil-
lary sequencing was performed on ABI Prism 3100-Avant
Genetic Analyzer instrument (Applied Biosystems) in both
directions using the Asp1 and Asp2 forward and reverse
primers. Figure 1 shows the thermal stability of the Asp1
and Asp2 amplicons along with their guanine and cyto-
sine (GC) content and melting temperatures (Tm). Sequenc-
ing data were then analyzed comparing to the databases
(http://blast.ncbi.nlm.nih.gov/BLAST.cgi) to clarify any
discrepancy.
Setting the optimal HRM-real time PCR conditions
In order to monitor the accumulation of the amplified prod-
ucts through real-time PCR reactions, to determine charac-
teristic melting-curve profiles and the representative melt-
ing temperatures (Tm) of the different strains, the real-time
Figure 1. Multiple alignment of the amplicons of the Asp1 (Asp1_1 - Asp1 6) and Asp2 (Asp2 1 - Asp2 6) melting domains in a 5’-3’ orientation
representing the interspecies variations. Asp1 (a) and Asp2 (b) forward and reverse primer sequences are highlighted in grey. Numbers and colors
specify the origin of the different target DNAmolecules: 1 red (A. fumigatus Af293); 2 blue (A. lentulus CBS 117885); 3 green (A. terreus FGSC A1156);
4 orange (A. flavus NRRL 11611); 5 yellow (A. niger CBS 11.346); 6 grey (A. tubingensis CBS 134.48). Amplicon and primer length, guanine and
cytosine (GC) content and melting temperatures (Tm) are also shown. Amplicon mismatches are depicted by black color. The sequence differences
of the amplicons will bring different melting temperature (Tm) values for the Asp1 and Asp 2 amplicons. This Figure is reproduced in color in the
online version of Medical Mycology.
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PCR amplification reactions of the target molecules were
conducted in a LightCycler 96 thermal cycler (Roche Di-
agnostics, Risch-Rotkreuz, Switzerland) instrument using
the High Resolution Master Mix 480 (Roche Applied Sci-
ence, Penzberg, Germany) that contained saturating double-
stranded DNA binding Light Cycler 480 ResoLight dye.
Figure 1 shows the forward and reverse Asp1 and Asp2
primer sequences.
 Annealing temperature optimization. Temperature gra-
dient assay was performed from 55 to 72◦C for assessing
the performance of the primer pair during amplification
with a temperature gradient program using the LightCy-
cler 96 Instrument.
 MgCl2 concentration optimization. The MgCl2 opti-
mization was performed by adding different amounts of
MgCl2 in the range 1 to 3.5 mM.
 Primer concentration optimization. The primer opti-
mization assay was performed using 0.2, 0.5, 0.8 μM of
the primer sets Asp1 and Asp2.
The 20 μl reactions consisted of 10 μl 2× LightCycler 480
High Resolution Melting Master (Roche Applied Science),
0.5–0.5 μl (0.2 μM) Asp1 and Asp2 primer sets in a 1:1
ratio, 2.4 μl MgCl2 (3 mM) and 6.6 μl template DNA
(20 ng/PCR reaction). There were two negative controls
without DNA (non-template control - NTC). The thermo-
cycling reactions (PCR) were conducted in a LightCycler
480 Multiwell Plate 96, white (Roche Diagnostics, Risch-
Rotkreuz, Switzerland) using an initial denaturing step of
95◦C for 10 minutes followed by 55 cycles of denaturation
at 95◦C for 10 s, annealing at 62◦C for 15 s and exten-
sion at 72◦C for 10 s. All fluorescent data were collected
in the ResolightDye channel (470/514 nm) of the PCR in-
strument at the end of the cycles. Following the completion
of real-time PCR, the products were denatured at 95◦C
for 60 s (4.4◦C/s) and then renatured at 40◦C for 60 s
to randomly form DNA duplexes. HRM analysis was per-
formed by increasing the temperatures from 65 to 95◦C
(0.04◦C/s) recording changes in fluorescence with changes
in temperature (dF/dT) and plotting against changes in tem-
perature. The HRM profiles were then analyzed using the
LightCycler R©96 Software Version 1.1 (Roche Diagnostics,
Risch-Rotkreuz, Switzerland).
Taxonomy footprints
To typify the fungal footprints of the Asp1-Asp2 HRM as-
say on the major, clinically relevant Aspergilli the primers
were used with the genomic DNA samples of the A. fumi-
gatus Af293, A. lentulus CBS 117885, A. terreus FGSC
A1156, A. flavus NRRL 11611, A. niger CBS 113.46,
A. tubingensis CBS 134.48 reference strains and with the
gDNA of the A. welwitschiae SZMC 2402 clinical isolate
depicted by ID35 in Table 1. Approximately 20 ng of ge-
nomic DNAwas used for every PCR reaction. To determine
the differences in thermal stability of the resulting ampli-
cons and representing the characteristic duplex Tm peaks
(LightCycler R©96 HRM analysis Software, Roche Diagnos-
tics) and the descriptive melting curve profiles of the differ-
ent strains samples were analyzed in duplicates.
Limit of detection
For measuring the analytical sensitivity of the Asp1-Asp2
HRM assay we artificially contaminated (spiked) PCR
grade water samples with fungal gDNA, and wemade seven
reference panels (A. fumigatus Af293 panel 1, A. lentulus
CBS 117885 panel 2, A. terreus FGSC A1156 panel 3, A.
flavus NRRL 11611 panel 4, A. niger CBS 113.46 panel 5,
A. welwitschiae ID-35 panel 6 and A. tubingensis CBS
134.48 panel 7). Serial dilution was made in a 5 log range
with 30 ng, 3 ng, 300 pg, 30 pg, 3 pg fungal gDNA in
6.6 μl nuclease free water (S1). Triplicate PCR reactions
were performed. Threshold cycle (Cq) data were estimated.
The correlation between Cq and genomic load was deter-
mined by linear regression plotting Cq values against the log
of genome number. Standard curves were built where the
linear ranges of these plots determined the linear dynamic
ranges. Efficiency was calculated according to the following
formula, E = (10 − 1 / slope). Efficiency was converted to
percentage efficiency by using the formula, E% = (E − 1)
× 100.42,43
Limit of reliable identification
For measuring the limit of reliable identification of the
Asp1-Asp2 HRM assay we estimated the lowest template
DNA concentration by which the joint appearance of
the Asp1 and Asp2melting domains are still observable.We
also compared the overlaying melting peaks of the melting
domains of the different Aspergillus reference panels to test
the different template DNA concentrations (30 ng – 300 fg)
providing reliable HRM patterns.
Cross reactions and discriminatory power
Possible cross reactions of the Asp1-Asp2 HRM assay
were tested with approximately 5–25 ng human genomic
DNA samples of human placenta (Sigma Aldrich, Mis-
souri, USA) and with gDNA samples of two Candida type
strains (Candida albicans ATCC 10231, C. parapsilosis
ATCC 22019), further seven Candida (ID44–50), three
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Aspergillus (ID41–43), six Fusarium (ID51–53), two Sce-
dosporium (ID57–58) isolates (Table 1).
The discriminatory power of the Asp1-Asp2 HRM assay
was tested on three Aspergillus gDNA panels (Aspergillus
panel 1, 2, 3) composed of 5–15 ng gDNA extracted
from the pure cultures of the Aspergillus clinical strains
(ID1-ID40) (Table 1) on three different days (plate 1, 2,
3). Duplicate PCR reactions were performed in case of
every sample with the Asp1-Asp2 primer sets of the du-
plexHRMassay. Following thermocycling reactions down-
stream HRM analysis was performed in a closed tube man-
ner in case of every single sample of the three Aspergillus
clinical panels (S2). Upon completion of the HRM analyses
Asp1 and Asp2 Tm data of the 40 different clinical strains
were subtracted and assigned to six Aspergillus species; A.
fumigatus, A. lentulus, A. terreus, A. flavus, A. niger, A.
welwitschiae, and A. tubingensis.
In-house quality assessment of Asp1-Asp2
duplex HRM assay
The aim was to estimate the precision of the Asp1-Asp2
HRM assay and to confirm that results generated are con-
sistent over time.
 Determining the repeatability. To estimate the intra-
assay consistency of the Asp1-Asp2 HRM assay coeffi-
cient of variation (% C.V.) was calculated for Asp1-Tm
and Asp2-Tm triplicate melting temperatures in case of
every sample of the six different Aspergillus reference
gDNA panels and on the A. welwitsciae ID35 clinical
gDNA panel. For this, standard deviation (±SD) of trip-
licates was taken, dividing that numbers by the means of
the triplicate values and multiplying them by 100 (S1).
Finally, the grand mean of the sample coefficient of vari-
ations (average % C.V.-s) of the triplicates was taken. In
case the intra-assay % C.V. is less than 10% the method
has high precision.
 Determining the reproducibility. Inter-assay consis-
tency (plate-to-plate variation) of the Asp1-Asp2 duplex
HRM assay was estimated between the three Aspergillus
clinical panels containing the DNA samples of 40 differ-
ent Aspergillus clinical strains. Duplicate PCR reactions
were performed on every sample on three different days
(plate 1, plate 2, plate 3). Asp1-Tm and Asp2-Tm means
were calculated (S2). Plate Tm duplicate means of adher-
ent clinical strains of the different species were assembled
and overall meanwas calculated. Plate coefficient of vari-
ations (% C.V.) was calculated (Table 2). Finally, grand
mean of the sample coefficient of variations (average %
C.V.-s) was taken. Inter-assay % C.V. values less than
15% are generally acceptable.
Results
In silico assessment of the discriminatory
capacity
Using the DNA sequence data of the GENE database
of the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/gene) we designed primers
based on Aspergillus benA sequences (Fig. 1a). First we as-
certained in advance that the Asp1-Asp2 HRM assay shows
sufficient diversity for the species level identification and
discrimination of relevant Aspergillus species by testing our
Asp1 and Asp2 primer sets with the gDNA isolates of the
reference A. fumigatus (Af293), A. lentulus (CBS 117885),
A. terreus (FGSCA1156),A. flavus (NRRL 11611),A. niger
(CBS 113.46), and A. tubingensis (CBS 134.48) strains. Af-
ter capillary sequencing we successfully re-identified the
resulted amplicon sequences. The approximate Asp1 and
Asp2 domain lengths proved to be about 136 ± 8 bp in
length. Melting temperature (Tm) data were calculated to
the Asp1 and Asp2 melting domains (range; 79–85.3◦C).
The mean melting temperature (Tm) values of the resulted
amplicons proved to be 82.27◦C± 1.91, suggesting that the
Asp1-Asp2 HRM assay shows sufficient diversity among
clinically relevant Aspergillus species allowing their identi-
fication (Fig. 1b).
Optimal reaction conditions
Optimal reaction conditions were determined as described
in the materials section. 0.2 μM primer concentration,
3 mM MgCl2 and annealing at 62 ◦C proved to be opti-
mal.
Footprints of the assay on different species
Asp1-Asp2 HRM assay was applied on panels contain-
ing approximately 20 ng of the genomic DNA of seven
Aspergillus strains. Following real-time PCR amplifica-
tions HRM analyses were performed. We were able to
source unambiguously the six clinically relevant A. fumi-
gatus (Af293), A. lentulus (CBS 117885), A. terreus (FGSC
A1156), A. flavus (NRRL 11611), A. niger (CBS 113.46),
A. tubingensis (CBS 134.48) reference strains and the A.
welwitschiae (ID35) clinical isolate on the basis of their
characteristic thermodynamic patterns and the relative dis-
tribution of their double (Asp1-Tm2 and Asp2-Tm1) melt-
ing peaks. Representative normalized peaks of the Asp1
and Asp2 melting domains are shown in Figure 2a. The
melting curves were normalized to eliminate differences
in background fluorescence and are shown in the form
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Table 2. Calculating inter-assay coefficient of variation of the Asp1-Asp2 duplex HRM assay.
Note: Asp1-Tm and Asp2-Tm duplicate means of adherent clinical strains of the different species were assembled in case of every plate and overall mean was
calculated. Plate coefficient of variation was calculated for the different species. Finally, grand mean of the sample coefficient of variations (average % C.V.-s) was
calculated.
Limit of detection and the limit of reliable
identification
The detection limit of the Asp1-Asp2 HRM assay was de-
termined on seven Aspergillus gDNA panels (S1) contain-
ing serially diluted genomic DNA samples in a 5-log range
(30 ng to 3 pg). In each case, triplicate PCR reactions were
performed to subtract threshold cycle (Cq) values and to
analyze overlaying Asp1 and Asp2 melting peaks of the dif-
ferent samples. To study the correlation between the Cq-s
of the qPCR and the genomic load standard curves were ob-
tained by plotting Cq values against the log of genome num-
ber (GE). Linear dynamic ranges (Fig. 3a), PCR efficiency
(E) and correlation coefficient (R2) were also estimated
using the standard curve data (Fig. 3b) of the different
Aspergillus panels. Along with measuring the analytical
sensitivity we also estimated the lowest concentration of
template DNA where reliable identification was attainable
with our assay on these gDNA panels. The lowest amount
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Figure 2. Independence of the template DNA belonging to the different Aspergillus species and the HRM melting profiles. (a). Distribution of
the double melting peaks barcoding the genomic DNA of the different Aspergillus species. The negative derivative of the fluorescence (F) over
temperature (T); -(dF/dT) curve displays representative plots and the representative Tm values for Aspergillus fumigatus Af293 (Tm1; 82.28◦C, Tm2;
86.80◦C), A. lentulus CBS 117885 (Tm1; 84.28◦C, Tm2; 86.85◦C), A. terreus IH2624 (Tm1; 84.39◦C, Tm2; 88.21◦C), A. flavus NRRL 11611(Tm1; 84.25◦C, Tm2;
87.60◦C) and A. niger CBS 11346 (Tm1; 83.19◦C, Tm2; 87.60◦C) and A. welwitschiae ID 35 (Tm1; 82.6◦C, Tm2; 87.60◦C) and A. tubingensis CBS 134.48
(Tm1; 83.21◦C, Tm2; 87.82◦C). (b). Representation of the normalized melting curves of Asp1-Asp2 HRM assay of the Asp1 and Asp2 melting domains.
Overlaying melting curves formed six discrete clusters. Asp2 primers form the first three melting clusters; melting curves of A. fumigatus (red)
and A. welwitschiae (pink) show no distinct difference in cluster_1, cluster 2 represents A. niger (yellow) and A. tubingensis (grey), while cluster 3
represents A. lentulus (blue), A. flavus (orange) and A. terreus (green). Asp1 primers form further three melting clusters; cluster 4 represents A.
fumigatus (red) and A. lentulus (blue), melting curves of A. flavus (orange), A. niger (yellow) and A. welwitschiae (pink) show no distinct difference in
cluster 5, while both A. tubingensis (grey) and A. terreus (green) fall into cluster 6. This Figure is reproduced in color in the online version of Medical
Mycology.
of the template DNA where reliable HRM curves were ob-
tainable with conclusive double peaks of the Asp1 and Asp2
melting domains proved to be 3 pg (102 GE) on all gDNA
panels (Figure 4b, 4g) but the A. fumigatus Af293 and the
A. tubingensis CBS 134.48 gDNA panels (Fig. 4a). In the
case of the A. fumigatus Af293 panel the Asp1-Asp2 du-
plex HRM assay provided unreliable melting curves in
the presence of 3 pg gDNA representing only a single,
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Figure 3. (a). Regression lines of Asp1-Asp2 HRM assay on Aspergillus gDNA panels. The limit of detection (LoD) of the combined Asp1-Asp2 HRM
assay was evaluated on seven various fungal gDNA panels of the reference Aspergillus fumigatus (Af293), A. lentulus (CBS 117885), A. terreus (FGSC
A1156), A. flavus (NRRL 11611), A. niger (CBS 113.46) and A. tubingensis (CBS 134.48) type strains and on the gDNA of the A. welwitschiae ID35
clinical isolate. In the case of the seventh (A. tubingensis CBS 134.48) panel the limit of reliable detection proved to be 10 GE (data not shown). (b).
Representation of slope, reaction efficiency (E %), error (±), coefficient of correlation (R2), and limit of detection (LoD). This Figure is reproduced in
color in the online version of Medical Mycology.
inconclusive melting domain of this sample (Fig. 4a). When
testing A. tubingensis CBS 134.48 gDNA panel, the reliable
LoD proved to be 300 fg (10 GE) (Fig. 4g).
Assay cross reactivity
The cross-reactivity of the Asp1-Asp2 HRM assay was ex-
amined with human genomic DNA (5–25 ng), Aspergilli
isolates (ID41-43), Candida type strains (Candida albicans
ATCC 10231, C. parapsilosis ATCC 22019), and Candida
(ID44-50), Fusarium (ID51-56) and Scedosporium (ID57–
58) clinical isolates (Table 1). No cross-amplification was
detected with the human genomic DNA and no misidentifi-
cation was observed when analyzing the above mentioned
strains. Moderate false-positivity was observed when
testing Candida gDNA samples generating cycle thresh-
old (Cq) values greater than Cq > 38, displaying incon-
clusive HRM curve shapes and peaks below <81.00 ◦C
(data not shown). Two Aspergillus isolates provided single
peaks (A. viridinutans at 85.38–85.41◦C; A. udagawae at
86.12–86.17◦C). Lack of double peak formation was also
detected when testing the Fusarium isolates (F. napiforme at
87.61–87.68◦C; F. delphinoides at 87.60◦C; F. verticilloides
at 87.81–87.90◦C; F. oxysporum at 87.30–87.56◦C; F.
solani at 87.44–87.57◦C; F. incarnatum at 86.31–86.44◦C).
Both Scedosporium aurantiacum isolates formed amor-
phous single peaks at 84.11–84.22◦C. The appearance of
the single peak formation underlines the significance of
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Figure 4. Overlaying melting peaks of the Asp1 and Asp2 melting domains of the different Aspergillus benA genes on different genomic DNA panels
and the limit of the reliable identification. The identification capacity of the Asp1-Asp2 assay proved to be reliable providing double melting peaks
on Asp1 (Tm2) and Asp2 (Tm1) melting domains in the presence of 30 ng – 3 pg template concentrations on all panels (b: A. lentulus, c: A. terreus, d:
A. flavus, e: A. niger, f: A. welwitschiae, g: A. tubingensis) but the A. fumigatus Af293 (a). In the case of this latter mentioned panel in the presence
of 3 pg template A. fumigatus Af293 gDNA the representative melting peak (Tm1) of the Asp2 melting domain did not appear. In the case of the A.
tubingensis CBS 134.48 panel (g) reliable double peak formation was also detected in the presence of 300 fg genomic DNA. This Figure is reproduced
in color in the online version of Medical Mycology.
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Maximum barcoding power was achieved by
allocating six melting peak windows and by the
consideration of the melting peak distances
 Estimating the barcoding accuracy of the Asp1-Asp2
HRM assay melting temperature data from the previ-
ously introduced Aspergillus reference DNA panels (A.
fumigatus Af293, A. lentulus CBS 117885, A. terreus
FGSC A1156, A. flavus NRRL 11611, A. niger CBS
113.46, A. tubingensis CBS 134.48) were taken and
grouped into 12 data groups according to their distri-
bution (Asp1 melting domain Tm data: group 1–6; Asp2
melting domain Tm data: group 7–12) and according
to the origin of the template DNA (A. fumigatus Af293:
gr 1, gr 7;A. lentulusCBS 117885: gr 2, gr 8;A. terreus
FGSC A1156: gr 3, gr 9; A. flavus NRRL 11611: gr 4,
gr 10; A. niger CBS 113.46: gr 5, gr 11; A. tubingensis
CBS 134.48: gr 6, gr 12) (Figure 5).
 Furthermore, three Aspergillus clinical panels (panel 1,
2, 3) were constructed containing samples of 5–15 ng
gDNA extracted from the pure cultures of the 40 avail-
able Aspergillus clinical strains (ID1–ID40). Upon com-
pletion of HRM analyses Asp1-Tm and Asp2-Tm data
were taken and assigned to seven Aspergillus species as
also shown in Figure 5; A. fumigatus (ID8–21) A. lentu-
lus (ID22–24), A. terreus (ID1–7), A. flavus (ID25–32),
A. niger (ID33–34), A. welwitschiae (ID35–38), and A.
tubingensis (ID39–40).
 Whisker plots were made where group1 to group12 rep-
resent the distribution of the melting domain Tm values
measured on the different Aspergillus reference panels
while group 13-group 26 show the distribution of the
Asp1 and Asp2 Tm values of the 40 Aspergillus clinical
panels (Fig. 5). For every data set the median, minimum,
maximum Tm values along with the 25th and 75th per-
centile are shown. According to the relative distribution
of the melting peaks of the different datasets we created
six melting clusters; cluster 1 (81.00–82.72◦C), cluster 2
(82.73–83.61◦C), cluster 3 (83.62–85.60◦C), cluster 4
(85.61–87.10◦C), cluster 5 (87.11–87.64◦C), cluster 6
(87.65–89.00◦C) for the accurate identification of the
differentAspergillus strains to the species level (Table 3).
 To enhance the discrimination betweenA. terreus (score
36) and A. flavus (score 35), A. lentulus (score 34) and
A. flavus (score 35), A. fumigatus (score 14) and A. wel-
witschiae (score 15) and the A. niger (score 25) and A.
welwitschiae (score 15), finally A. niger (score 25) and
A. tubingensis (score 26) sharing one clusters in com-
mon and adjacent clusters we also suggest considering
the peak distances as an adjunct parameter when barcod-
ing the species (Fig. 6a). Species specific Asp1 and Asp2
peak Tm values were used for measuring the median
of the Tm difference data (Fig. 6b–6c). Mann–Whitney
statistics was used to compare the Asp1–Asp2 peak Tm
difference data sets. It was estimated that the difference
in species specific data sets (35 vs. 36, 34 vs. 35, 14 vs.
15, 15 vs. 25, and 25 vs. 26) is greater (P = <.001) than
would be expected by chance representing a statistically
significant difference between the species (A. flavus vs.A.
terreus andA. lentulus,A. fumigatus vs.A. welwitschiae,
finally A. niger vs. A. welwitschiae and A. tubingensis)
tested.
Asp1–Asp2 HRM assay passed the in-house
quality assessment
To assess the repeatability of the Asp1–Asp2 HRM assay
we applied on the six Aspergillus reference panels (A. fumi-
gatus Af293, A. fumigatus Af293, A. lentulus CBS 117885,
A. terreus FGSC A1156, A. flavus NRRL 11611, A. niger
CBS 113.46, A. tubingensis CBS 134.48) and on the A.
welwitschiae ID35 panel. For measuring the precision of
the assay average coefficient of variation was calculated for
the triplicate Asp1 and Asp2 mean Tm values where intra-
assay % C. V. proved to be 0.09% accounting for a very
high accuracy of the assay (S1). Plate-to-plate consistency
was also assessed for the assay on three Aspergillus clinical
panels (panel 1, 2, 3) on three different days compos-
ing of 5–15 ng genomic DNA of the 40 different clinical
isolates (S2). Inter-run precision (reproducibility) was mea-
sured between three Aspergillus clinical panels and sample
coefficient of variations (average % C.V.-s) between the
three plates were taken, where inter-assay % C.V proved
to be 2.44% (Table 2), which is highly acceptable.
Discussion
Aspergillosis is the most common invasive mold disease
worldwide,5 and to data, there is a growing number of
various molecular methods to identify biological sam-
ples contaminated with traces of Aspergillus conidia or
DNA.23,26,27,30–34 Rapid and noninvasive molecular bar-
coding methods for detecting and identifying pathogens di-
rectly from clinical samples are under the spotlight35–39
since most cultured specimens have only a single dominant
causative agent;44,45 furthermore, the number of clinically
relevant Aspergillus species may also be limited.46 Recent
data also support that applications resting on high resolu-
tion melting analyses may be ideally suited for barcoding
of fungal pathogens.44–49
Species level identification of the Aspergillus species may
be important especially in case of the cryptic species because
some of these strains are associated with special growth
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Figure 5. Whisker plots showing the distribution of the melting-temperatures (Tm) of the Asp1 and Asp2 melting domains for the six distinct melting
clusters in case of the 22 different datasets. Asp1 and Asp2 amplicon melting temperature data (Tm) were ordered into 26 groups according to the
origin of the template DNA target molecules and the Asp1 and Asp2 primer sets used to amplify certain regions of the Aspergillus benA genes.
Temperatures of melting (Tm) data were substracted from the analysis of the six Aspergillus reference panels (data groups 1-12) and from the three
Aspergillus clinical panels (data groups 13-26). Whisker plots were constructed for each data group showing the range of obtained temperatures of
melting (Tm); the minimum, the median, and the maximum Tm values with 25th and 75th percentiles. Figure 5 also displays the melting temperature
regions of the six pre-set melting clusters (cluster 1 – cluster 6) they were allocated according to the relative localization of the whisker plots.
Cluster 1 (81.00 – 82.72◦C); cluster 2 (82.73 – 83.61◦C); cluster 3 (83.62 – 85.60◦C); cluster 4 (85.61 – 87.10◦C); cluster 5 (87.11 – 87.64◦C); cluster 6
(87.65 – 89.00◦C). This Figure is reproduced in color in the online version of Medical Mycology.
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Table 3. Representation of the six melting peak cluster (cluster 1-cluster 6) Tm ranges of the Asp1 and Asp2 melting domains.
Note: Representation of the six melting peak cluster (cluster 1–cluster 6) Tm ranges of the Asp1 and Asp2 melting domains with the mean melting temperatures
and standard deviations (±SD) assigned to the different clinical strains on completion of the analyses of the three Aspergillus clinical panels. Binomial scores
were generated in case of the different strains tested according to their Asp1 and Asp2 melting clusters (cluster 1; score 1, cluster 2; score 2, cluster 3; score 3,
cluster 4; score 4, cluster 5; score 5, cluster 6; score 6) unequivocally defining the different species according to their binomial scores; (14) for A. fumigatus, (34)
for A. lentulus, (36) for A. terreus, (35) for A. flavus, (25) for A. niger, (15) for A. welwitschiae, (26) for A. tubingensis.
features and antifungal resistance.14,43,50–53 Reliable,
species level detection of the typically moderately-growing
fungi from cultured specimens may take several days34 de-
laying adequate diagnosis and setting back the timely ini-
tiation of appropriate antifungal treatment. Prompt, cor-
rect, species level identification of pathogen fungi further-
more requires nucleic acid based techniques.30–34 Although
HRM based methods do not have the resolving power as
the sequencing or are not as sensitive as the TaqMan probe
based systems, they became more and more attractive to
molecular diagnostic laboratories.35,39
Multiple studies have demonstrated the limited utility
and enhanced major drawbacks of morphotyping used
alone for species identification of clinically relevant As-
pergilli recognizing that DNA based applications used in
tandem with morphological examinations can offer better
resolution of species within the genus.14 The prime aim of
this study was to describe a method that may be promising
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Figure 6. (a). 3D scatter plot representing the distinct habitats of the different type strains and clinical isolates of the 40 Aspergilli depicted by
seven species specific colors; A. fumigatus: red, A. lentulus: blue, A. terreus: green, A. flavus: orange, A. niger: yellow, A. welwitschiae: pink and A.
tubingensis: grey. Position of the spots was specified by the section of the three axes; scale x was determined by Tm data (◦C) of the Asp1 peaks,
scale y was determined by the Tm data (◦C) of the Asp2 peaks while scale z was determined by the difference in Tm data (delta ◦C) of the Asp1
and Asp2 peaks. (b). Bar diagrams showing the difference in Asp1 and Asp2 Tm data with standard deviations. (c). Vectors representing the mean
Asp1-Asp2 Tm peak distances with their relative localizations. This Figure is reproduced in color in the online version of Medical Mycology.
especially to traditional culturing techniques in virtue of
identifying numerous clinical isolates of relevant Aspergilli
to species with very high accuracy.
Our Asp1–Asp2 HRMmethod introduced here uses two
primer sets (Asp1 and Asp2) targeting two differently con-
served regions (Asp1 and Asp2 melting domains) of the As-
pergillus benA genes. On the basis of the thermodynamic
characteristics of the amplicons and the joint appearance
of the melting peaks of the Asp1 and Asp2 melting do-
mains and their Tm peak distances, our assay was shown to
have higher resolution power displaying deviations among
species than other single locus based HRM systems. This
enables us to identify the gDNAs derived from 40 clinical
isolates of the relevant opportunistic infectious agents (A.
fumigatus,A. lentulus,A. terreus,A. flavus,A. niger, A. wel-
witschiae, and A. tubingensis) based on the thermodynamic
characteristics of the amplicons with very high accuracy.
The specificity of the Asp1–Asp2 HRM assay was tested
thoroughly in silico. The Asp1 and Asp2 amplicons of the
six reference strains (A. fumigatus Af293, A. lentulus CBS
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117885, A. terreus FGSC A1156, A. flavus NRRL 11611,
A. niger CBS 113.46, A. tubingensis CBS 134.48) were se-
quenced; then the sequences were aligned surveying poten-
tial sequence deviations within species. Based on our data
we presumed that our Asp1 and Asp2 amplicons will dis-
play enough sequence divergence between closely related
species but at the same time may be conserved enough tar-
geting the different clinical isolates within species.
In the work presented here the gDNA of six Aspergillus
reference and further 40 clinical isolates were used as a
proof of concept. Furthermore, our Asp1–Asp2 duplex
HRM assay was tested and optimized experimentally on
human gDNA and on relevant Candida, Fusarium, Sce-
dosporium strains (Table 1). Neither the human gDNA,
nor the clinical isolates resulted misidentification with our
assay. We also proved that even the presence of excess hu-
man gDNA did not affect assay results.
Molecular barcoding of the different strains was con-
ducted by real-time PCR amplification; then species dis-
crimination was performed by analyzing of the character-
istic thermodynamic profiles using generic double-stranded
DNA binding fluorescent dyes. When testing the gDNA
panels of the six type strains (A. fumigatus, A. lentulus, A.
terreus, A. flavus, A. niger, A. tubingensis) along with the
A. welwitschiae we managed to identify altogether six dis-
tinct melting clusters. Asp1 melting domain contains clus-
ter 4; 85.61–87.10◦C, cluster 5; 87.11–87.64◦C, cluster 6;
87.65–89.00◦C, while Asp2 melting domain contains clus-
ter 1; 81.00–82.72◦C, cluster 2; 82.73–83.61◦C, cluster 3;
83.62–85.60◦C.
When testing DNA samples of the numerous Aspergillus
clinical strains (ID1–40) they displayed conclusive, species
specific double melting peaks in the presence of 5–15 ng
Aspergillus gDNA. Conversely, the peaks of the Asp1 and
Asp2 domains of the examined Aspergilli were then as-
signed to the respective melting clusters. Binomial scores
given to the strains unequivocally identified all the 40 ex-
amined Aspergilli (Table 3); thus, the species barcoding ac-
curacy of the method proved to be 100%. The analytical
sensitivity of this assay was also measured and proved to
be 102 or lower GE on all reference panels but the A. fu-
migatus panel. This information may be necessary when
testing different liquid tissue samples that yield low copy
numbers of fungal DNA, which is often the case when fun-
gal gDNA is extracted from bronchoalveolar lavage (BAL),
whole blood, serum, or plasma samples.
We also estimated the identification limit of the Asp1–
Asp2HRMassay by analyzing the overlayingmelting peaks
of the different melting clusters. From the observed cluster
patterns, we concluded that our HRM assay is specific,
provides highly reproducible thermodynamic characteris-
tics (Fig. 4), and could detect the subtle sequence differences
of the Asp1 and Asp2 melting domains preferentially when
extracting gDNA from young fungal cultures followed bead
beating of the hyphae and conidia. In-house assay perfor-
mance measurements were also conducted confirming the
high accuracy and reproducibility of the Asp1–Asp2 assay.
We also confirmed that Asp1 and Asp2 HRM assay results
may be consistent over time using the same PCR-HRM
platform.
Our prime purpose was to introduce a simple, robust,
and highly reproducible molecular barcoding tool that re-
lies on HRM analysis. This article describes a rapid, prac-
tical and precise DNA typing method with a high resolu-
tion power for the molecular identification of relevant As-
pergillus clinical isolates to the species level. We believe that
this method should be also applied in other research or diag-
nostic laboratories when more strains were available to test
further relevant Aspergillus clinical isolates and to prove its
applicability or to reveal possible drawbacks. Asp1–Asp2
may be capable to distinguish all clinically relevant strains
of the above tested Aspergilli even at limiting initial tem-
plate concentrations so the diagnostic power of our method
should be further investigated on liquid tissue specimens.
Nevertheless, just like other HRM based applications our
molecular barcoding method introduced here possesses in-
herent simplicity so may be amenable for automatization.
We hope that our method will help to identify and discrim-
inate causative agents of aspergillosis more promptly and
accurately giving more insight into the pathogenesis and
treatment of infection.
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